Ancora Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Ancora Advisors's RMD Position: Q1 2026 in Review
Ancora Advisors increased its ResMed (RMD) stake by 29% in Q1 2026, buying an estimated $5.73K and bringing the position to 102 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1488.
Ancora Advisors first reported a position in RMD in Q4 2022 and has held it in 8 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Ancora Advisors held 102 shares of ResMed worth $22.9K as of Q1 2026.
- Ancora Advisors bought 23 ResMed shares in Q1 2026, an estimated $5.73K.
- ResMed made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1488 holding.
- Ancora Advisors first reported a position in ResMed in Q4 2022 and has held it in 8 quarters since.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.